Tumor-penetrating therapy for β5 integrin-rich pancreas cancer
The iRGD tumor-penetrating peptide can achieve tumor specific drug delivery but whether and how it can penetrate into desmoplastic tumors is unknown. Here, the authors show that β5 integrin expression on tumor cells, mediated by CAFs-derived TGF-β, is required for iRGD penetration into the desmoplas...
Main Authors: | Tatiana Hurtado de Mendoza, Evangeline S. Mose, Gregory P. Botta, Gary B. Braun, Venkata R. Kotamraju, Randall P. French, Kodai Suzuki, Norio Miyamura, Tambet Teesalu, Erkki Ruoslahti, Andrew M. Lowy, Kazuki N. Sugahara |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-03-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-021-21858-1 |
Similar Items
-
Tumor penetrating peptides
by: Tambet eTeesalu, et al.
Published: (2013-08-01) -
Increasing Tumor Accessibility with Conjugatable Disulfide-Bridged Tumor-Penetrating Peptides for Cancer Diagnosis and Treatment
by: Venkata Ramana Kotamraju, et al.
Published: (2016-06-01) -
Increasing Tumor Accessibility with Conjugatable Disulfide-Bridged Tumor-Penetrating Peptides for Cancer Diagnosis and Treatment
by: Venkata Ramana Kotamraju, et al.
Published: (2015-01-01) -
Hyaluronan-binding peptide for targeting peritoneal carcinomatosis
by: Hideki Ikemoto, et al.
Published: (2017-04-01) -
In vivo cation exchange in quantum dots for tumor-specific imaging
by: Xiangyou Liu, et al.
Published: (2017-08-01)